Inncelerex

Inncelerex is a US-based company specializing in supporting drug development across all stages, including candidate selection, toxicology, pre-clinical, early clinical development, late-phase clinical trials, drug registration and post marketing requirements.

Our integration of scientific and regulatory expertise in clinical pharmacology, modeling and simulation, translational medicine, toxicology and pre-clinical safety offers comprehensive solutions which serve to enhance program design, execution and strategic decision-making.

We manage a broad spectrum of studies, including clinical pharmacology, pharmacometrics, pharmacodynamics, toxicology, and ADME studies, ensuring program efficiency and precision.

Our team, led by CEO & Founder Parviz Ghahramani, brings decades of experience from major pharmaceutical companies like Pfizer and Roche, with a proven track record of successful drug development and regulatory approvals.

We provide comprehensive support from pre-clinical through clinical development, offering expertise in areas such as clinical pharmacology, pharmacometrics, and regulatory interactions.